Recently, we described a genetic model in which tamoxifen-induced neural stem cell (NSC)-specific deletion of Pten and p53 results in the development of brain tumors, which were classified as high-grade gliomas (glioblastomas) according to histopathological (necrosis and microvascular proliferation) and molecular features. The gene discussed is TP53; the disease is glioblastoma.